Ocular manifestation of Monkeypox infection
A. Isolate the patient and notify public health authorities
A 2022 outbreak of human monkeypox (HMPX) has recently gained global attention. As of July 1, 2022, there were 5783 total confirmed cases in 52 locations, the majority of whom were reported in Europe, with 1235 confirmed cases in the United Kingdom. A few different variants have been detected. Most of cases occurred in young men after close contact with infected individuals.1
HMPX is a zoonosis caused by infection with the Monkeypox virus, an Orthopoxyvirus of the Poxvyridae family. The disease was first described in central Africa2 in 1970 and has historically affected some of the poorest communities in the world,3 being rarely exported from the African continent.4 Commonly reported clinical features include fever, headache, muscle aches, backache, swollen lymph nodes, chills, exhaustion, and a skin rash, characterized by pimple- or blisterlike lesions that appear on the face, hands, feet, chest, genitals, or anus. The illness typically lasts 2 to 4 weeks. Complications include pneumonia, encephalitis, and secondary bacterial infections.4,5